Tratamentul tulburărilor obsesiv-compulsive.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
N06AB08 FLUVOXAMINUM COMPR. FILM. 100 mg
FEVARIN(R) 100 100 mg SOLVAY PHARMACEUTICALS BV
FLUVOXAMINE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL
N06AB08 FLUVOXAMINUM COMPR. FILM. 50 mg
FEVARIN(R) 50 50 mg SOLVAY PHARMACEUTICALS BV
FLUVOXAMINE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL
________________________________________________________________________________
______________________________________________________________________________
| 136 |N06AX03| MIANSERINUM* | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
N06AX03 MIANSERINUM COMPR. FILM. 10 mg
MIANSERIN 10 10 mg REMEDICA LTD.
N06AX03 MIANSERINUM DRAJ. 10 mg
MIANSERIN 10 mg 10 mg TERAPIA SA
N06AX03 MIANSERINUM COMPR. FILM. 30 mg
MIANSERIN 30 30 mg REMEDICA LTD.
N06AX03 MIANSERINUM DRAJ. 30 mg
MIANSERIN 30 mg 30 mg TERAPIA SA
________________________________________________________________________________
______________________________________________________________________________
| 137 |N06AX11| MIRTAZAPINUM* | |
|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul episoadelor depresive majore.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
N06AX11 MIRTAZAPINUM COMPR. DISP. 15 mg
REMERON(R) SOLTAB 15 mg 15 mg ORGANON NV
N06AX11 MIRTAZAPINUM COMPR. FILM. 15 mg
ESPRITAL(R) 15 15 mg ZENTIVA AS
MIRZATEN(R) 15 mg 15 mg KRKA D.D.
N06AX11 MIRTAZAPINUM COMPR. DISP. 30 mg
REMERON(R) SOLTAB 30 mg 30 mg ORGANON NV
N06AX11 MIRTAZAPINUM COMPR. FILM. 30 mg
ESPRITAL(R) 30 30 mg ZENTIVA AS
MIRTAZAPINE-TEVA 30 mg 30 mg TEVA PHARMACEUTICALS SRL
MIRZATEN(R) 30 mg 30 mg KRKA D.D.
PHARMATAZ 30 mg 30 mg ACTAVIS GROUP HF.
N06AX11 MIRTAZAPINUM COMPR. DISP. 45 mg
REMERON(R) SOLTAB 45 mg 45 mg ORGANON NV
N06AX11 MIRTAZAPINUM COMPR. FILM. 45 mg
ESPRITAL(R) 45 45 mg ZENTIVA AS
MIRZATEN(R) 45 mg 45 mg KRKA D.D.
________________________________________________________________________________
______________________________________________________________________________
| 138 |N06AX16| VENLAFAXINUM** | Protocol: N013F |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
N06AX16 VENLAFAXINUM CAPS. ELIB. PREL. 150 mg
EFECTIN ER 150 mg 150 mg WYETH LEDERLE PHARMA GMBH
VELAXIN 150 mg 150 mg EGIS PHARMACEUTICALS
P.L.C.
N06AX16 VENLAFAXINUM COMPR. 37.5 mg
VELAXIN 37,5 mg 37.5 mg EGIS PHARMACEUTICALS PLC
VENLAFAXINA LPH 37,5 mg 37.5 mg LABORMED PHARMA SA
N06AX16 VENLAFAXINUM CAPS. ELIB. PREL. 75 mg
EFECTIN ER 75 mg 75 mg WYETH LEDERLE PHARMA GMBH
VELAXIN 75 mg 75 mg EGIS PHARMACEUTICALS
P.L.C.
N06AX16 VENLAFAXINUM COMPR. 75 mg
VELAXIN 75 mg 75 mg EGIS PHARMACEUTICALS PLC
VENLAFAXINA LPH 75 mg 75 mg LABORMED PHARMA SA
________________________________________________________________________________
______________________________________________________________________________
| 139 |N07AA01| NEOSTIGMINI BROMIDUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
N07AA01 NEOSTIGMINI BROMIDUM SOL. INJ. 0.5 mg/ml
MIOSTIN 0,5 mg/ml 0.5 mg/ml ZENTIVA S.A.
N07AA01 NEOSTIGMINI BROMIDUM COMPR. 15 mg
NEOSTIGMINA LPH 15 mg 15 mg LABORMED PHARMA SA
________________________________________________________________________________
______________________________________________________________________________
| 140 |P01AB01| METRONIDAZOLUM | |
|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul infecţiilor cu anaerobi.
Tratamentul infecţiilor cu protozoare sensibile la
metronidazol.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
P01AB01 METRONIDAZOLUM COMPR. 250 mg
METRONIDAZOL 250 mg (P01AB01) 250 mg ZENTIVA SA
METRONIDAZOL 250 mg (P01AB1) 250 mg ARENA GROUP SA
P01AB01 METRONIDAZOLUM COMPR. FILM. 250 mg
FLAGYL 250 mg LABORATOIRE AVENTIS
P01AB01 METRONIDAZOLUM SUSP. ORALA 4%
FLAGYL 4% (P01AB01) 4% LABORATOIRE AVENTIS
________________________________________________________________________________
______________________________________________________________________________
| 141 |P01AB02| TINIDAZOLUM | |
|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul infecţiilor cu anaerobi.
Tratamentul infecţiilor cu protozoare sensibile la
metronidazol.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
P01AB02 TINIDAZOLUM COMPR. FILM. 500 mg
FASIGYN (P01AB02) 500 mg PFIZER EUROPE MA EEIG
TINIZOL(R) 500 mg (P01AB02) 500 mg ZENTIVA S.A.
TIPROGYN 500 500 mg AC HELCOR SRL
P01AB02 TINIDAZOLUM COMPR. FILM. 500 mg
FASIGYN (P01AB02) 500 mg PFIZER EUROPE MA EEIG
TINIZOL(R) 500 mg (J01XD02) 500 mg ZENTIVA S.A.
TIPROGYN 500 500 mg AC HELCOR SRL
________________________________________________________________________________
______________________________________________________________________________
| 142 |P02CA03| ALBENDAZOLUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
P02CA03 ALBENDAZOLUM SUSP. ORALA 0.4 g/10 ml
ZENTEL 0,4 g/10 ml 0.4 g/10 ml GLAXOSMITHKLINE EXPORT
LTD.
P02CA03 ALBENDAZOLUM COMPR. FILM. 200 mg
DUADOR 200 mg 200 mg GEDEON RICHTER ROMANIA SA
ZENTEL 200 mg 200 mg GLAXOSMITHKLINE EXPORT
LTD.
P02CA03 ALBENDAZOLUM COMPR. 400 mg
ESKAZOLE 400 mg GLAXO SMITHKLINE EXPORT
LTD.
P02CA03 ALBENDAZOLUM SUSP. ORALA 400 mg
ALBENDAZOL BIOFARM 400 mg 400 mg BIOFARM S.A.
P02CA03 ALBENDAZOLUM COMPR. FILM 200 mg
ALBENDAZOL 200 mg OZONE LABORATORIES LTD.
________________________________________________________________________________
______________________________________________________________________________
| 143 |P02CE01| LEVAMISOLUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
P02CE01 LEVAMISOLUM COMPR. 150 mg
DECARIS 150 mg 150 mg GEDEON RICHTER ROMANIA SA
P02CE01 LEVAMISOLUM COMPR. 50 mg
DECARIS 50 mg 50 mg GEDEON RICHTER ROMANIA SA
________________________________________________________________________________
______________________________________________________________________________
| 144 |R03AC02| SALBUTAMOLUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03AC02 SALBUTAMOLUM SUSP. INHAL PRESURIZATĂ 100 µg/doză
ASTHALIN INHALER 100 µg/doză CIPLA (UK) LIMITED
ECOSAL Easi-Breath 100 µg/doză IVAX-PHARMACEUTICALS
S.R.O.
VENTOLIN 100 INHALER CFC-FREE 100 µg/doză GLAXOWELLCOME UK LTD.
R03AC02 SALBUTAMOLUM SOL. INHAL. 5 mg/ml
VENTOLIN(R) 5 mg/ml GLAXOWELLCOME UK LTD.
________________________________________________________________________________
______________________________________________________________________________
| 145 |R03BA01| BECLOMETASONUM* | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03BA01 BECLOMETASONUM AEROSOL SOL. INHAL. 100 µg/doză
ECOBEC 100 µg 100 µg/doză IVAX-PHARMACEUTICALS
CFC FREE S.R.O.
ECOBEC EASI-BREATHE 100 µg/doză IVAX-PHARMACEUTICALS
100 µg CFC FREE S.R.O.
R03BA01 BECLOMETASONUM SPRAY NAZ., SUSP. 100 µg/doză
RINOCLENIL 100 100 µg/doză CHIESI FARMACEUTICI S.P.A.
R03BA01 BECLOMETASONUM AEROSOL SOL. INHAL. 250 µg/doză
ECOBEC 250 µg/doză 250 µg/doză IVAX-PHARMACEUTICALS
CFC FREE S.R.O.
ECOBEC EASI-BREATHE 250 µg/doză IVAX-PHARMACEUTICALS
250 µg/doză CFC FREE S.R.O.
R03BA01 BECLOMETASONUM SOL. DE INHALAT 250 µg/doză
PRESURIZATĂ
BECLOFORTER(R) CFC-Free 250 µg/doză GLAXO WELLCOME UK LTD.
R03BA01 BECLOMETASONUM SOL. INHALAT 250 µg/doză
PRESURIZATĂ
CLENIL(R) JET 250 µg/doză CHIESI FARMACEUTICI SPA
250 µg/doză
R03BA01 BECLOMETASONUM SOL. DE INHALAT 50 µg/doză
PRESURIZATĂ
BECOTIDER(R) CFC-Free 50 µg/doză GLAXO WELLCOME UK LTD.
________________________________________________________________________________
______________________________________________________________________________
| 146 |R03BA02| BUDESONIDUM* | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03BA02 BUDESONIDUM PULB. INHAL. 200 µg/doză
FRENOLYN 200 200 µg/doză MEDOCHEMIE ROMÂNIA SRL
R03BA02 BUDESONIDUM PULB. INHAL. 200 µg/doză
PULMICORT TURBUHALER 200 µg/doză ASTRAZENECA AB
200 µg/doză
R03BA02 BUDESONIDUM PULB. INHAL. 400 µg/doză
FRENOLYN 400 400 µg/doză MEDOCHEMIE ROMÂNIA SRL
________________________________________________________________________________
______________________________________________________________________________
| 147 |R03BB01| IPRATROPII BROMIDUM* | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03BB01 IPRATROPII BROMIDUM AEROSOL 20 µg/doză
IPRAVENT 20 - INHALER 20 µg/doză CIPLA (UK) LIMITED
________________________________________________________________________________
______________________________________________________________________________
| 148 |R03CC02| SALBUTAMOLUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03CC02 SALBUTAMOLUM SOL. ORALA 0.04%
SALBUTAMOL T 0.04% TIS FARMACEUTIC SA
R03CC02 SALBUTAMOLUM SOL. INJ. 0.5 mg/ml
VENTOLIN(R) 0.5 mg/ml GLAXO WELLCOME UK LTD.
R03CC02 SALBUTAMOLUM SIROP 2 mg/5 ml
SALBUTAMOL EIPICO 2 mg/5 ml 2 mg/5 ml E.I.P.I.CO. MED S.R.L.
VENTOLIN(R) 2 mg/5 ml GLAXOWELLCOME UK LTD.
R03CC02 SALBUTAMOLUM SOL. ORALA 2 mg/5 ml
SALBUTAMOL 2 mg/5 ml TERAPIA S.A.
________________________________________________________________________________
______________________________________________________________________________
| 149 |R03DA04| THEOPHYLLINUM | |
|_______|_______|____________________________________________|_________________|
Datorită efectelor variabile ale alimentelor asupra absorbţiei teofilinei, pacienţii care folosesc un anumit preparat nu trebuie să îi schimbe cu un altul fără o monitorizare adecvată.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 100 mg
TEOFIUNA SR 100 mg 100 mg TERAPIA SA
THEO SR 100 100 mg GLAXOSMITHKLINE (GSK) SRL
R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 200 mg
TEOFIUNA SR 200 mg 200 mg TERAPIA SA
TEOTARD(R) 200 200 mg KRKA D.D.
THEO SR 200 200 mg GLAXOSMITHKLINE (GSK) SRL
R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 300 mg
TEOFILINA SR 300 mg 300 mg TERAPIA SA
THEO SR 300 300 mg GLAXOSMITHKLINE (GSK) SRL
R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 350 mg
TEOTARD(R) 350 350 mg KRKA D.D.
R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 50 mg
TEOFILINA SR 50 mg 50 mg TERAPIA SA
________________________________________________________________________________
______________________________________________________________________________
| 150 |R05DA04| CODEINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R05DA04 CODEINUM COMPR. 15 mg
CODEINA FOSFAT 15 mg SLAVIA PHARM SRL
CODEINA FOSFAT 15 mg 15 mg OZONE LABORATORIES LTD.
CODEINA FOSFAT LPH 15 mg 15 mg LABORMED PHARMA SA
CODEINA FOSFORICĂ 15 mg BIO EEL SRL
CODEINA FOSFORICĂ 15 mg 15 mg MAGISTRA C & C
FARMACOD 15 mg FARMACOM SA
FOSFAT DE CODEINĂ 15 mg 15 mg SINTOFARM SA
________________________________________________________________________________
______________________________________________________________________________
| 151 |R06AB04| CHLORPHENAMINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R06AB04 CHLORPHENAMINUM COMPR. 4 mg
CLORFENIRAMIN 4 mg LABORMED PHARMA SA
________________________________________________________________________________
______________________________________________________________________________
| 152 |R06AE07| CETIRIZINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R06AE07 CETIRIZINUM COMPR. FILM. 10 mg
CELERG 10 mg AC HELCOR PHARMA SRL
R06AE07 CETIRIZINUM COMPR. FILM. 10 mg
LETIZEN(R) 10 mg 10 mg KRKA D.D.
R06AE07 CETIRIZINUM SOL. ORALA 1 mg/ml
LETIZEN 1 mg/ml KRKA D.D.
R06AE07 CETIRIZINUM PICĂTURI ORALE - SOL. 10 mg/ml
ZYRTEC(R) 10 mg/ml U.C.B. GMBH
________________________________________________________________________________
______________________________________________________________________________
| 153 |R06AX17| KETOTIFENUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R06AX17 KETOTIFENUM CAPS. 1 mg
KETOF 1 mg 1 mg HEXAL AG
R06AX17 KETOTIFENUM COMPR. 1 mg
H-KETOTIFEN 1 mg AC HELCOR SRL
KETOTIFEN 1 mg MAGISTRA C & C
KETOTIFEN LPH(R) 1 mg 1 mg LABORMED PHARMA SA
R06AX17 KETOTIFENUM SIROP 1 mg/5 ml
FRENASMA 1 mg/5 ml FARAN LABORATORIES S.A.
KETOF 1 mg/5 ml 1 mg/5 ml HEXAL AG
________________________________________________________________________________
______________________________________________________________________________
| 154 |S01AX13| CIPROFLOXACINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01AX13 CIPROFLOXACINUM UNG. OFT. 0.3%
CIPLOX 0.3% CIPLA (UK) LIMITED
________________________________________________________________________________
______________________________________________________________________________
| 155 |S01BC03| DICLOFENACUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01BC03 DICLOFENACUM PICĂTURI OFT. - SOL. 0.1%
DICLOGESIC 0,1% PICĂTURI 0.1% DAR AL DAWA PHARMA S.R.L.
OFTALMICE, SOLUŢIE
UNICLOPHEN(R) 0,1% 0.1% UNIMED PHARMA LTD.
VOLTAREN OPHTHA CD 0.1% NOVARTIS PHARMA GMBH
S01BC03 DICLOFENACUM PIC. OFT. - SOL. 1 mg/ml
DICLOFENAC RPH 1 mg/ml ROMPHARM COMPANY SRL
S01BC03 DICLOFENACUM PIC. OFT. - SOL. 1 mg/ml
VURDON 1 mg/ml HELP S.A. PHARMACEUTICALS
________________________________________________________________________________
______________________________________________________________________________
| 156 |S01CA05| COMBINAŢII (BETHAMETASONUM + | |
| | | ANTIINFECŢIOASE) | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01CA05 COMBINAŢII UNG. OFT. 0,2 g + 0,5 g
(BETHAMETASONUM +
ANTIINFECŢIOASE)
BETABIOPTAL 0,2 g + 0,5 g FARMILA FARMACEUTICI
S01CA05 COMBINAŢII PICĂTURI OFT. SUSP. 0,2 g + 0,5 g
(BETHAMETASONUM +
ANTIINFECŢIOASE)
BETABIOPTAL 0,2 g + 0,5 g FARMILA FARMACEUTICI
MILANO SPA
________________________________________________________________________________
SUBLISTA B - MEDICAMENTE CU NIVEL DE COMPENSARE 50% DIN PREŢUL DE REFERINŢĂ
______________________________________________________________________________
| 157 |A02BC02| PANTOPRAZOLUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A02BC02 PANTOPRAZOLUM COMPR. FILM. GASTROREZ. 20 mg
CONTROLOC 20 mg 20 mg ALTANA PHARMA AG
Prescriere limitată: Menţinerea rezultatelor terapiei refluxului gastro-esofagian
Prescriere limitată: Boala de reflux gastro-esofagian
Prescriere limitată: Profilaxia ulcerului gastro-duodenal asociat tratamentului cu antiinflamatoare nesteroidiene pe termen lung la pacienţii cu factori de risc gastrointestinal.
Dostları ilə paylaş: |